Cargando…

Recent Advances in (64)Cu/(67)Cu-Based Radiopharmaceuticals

Copper-64 (T(1/2) = 12.7 h) is a positron and beta-emitting isotope, with decay characteristics suitable for both positron emission tomography (PET) imaging and radiotherapy of cancer. Copper-67 (T(1/2) = 61.8 h) is a beta and gamma emitter, appropriate for radiotherapy β-energy and with a half-life...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krasnovskaya, Olga O., Abramchuck, Daniil, Erofeev, Alexander, Gorelkin, Peter, Kuznetsov, Alexander, Shemukhin, Andrey, Beloglazkina, Elena K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288943/ https://www.ncbi.nlm.nih.gov/pubmed/37298101 http://dx.doi.org/10.3390/ijms24119154

Ejemplares similares

Pt(IV) Prodrugs with NSAIDs as Axial Ligands
por: Spector, Daniil, et al.
Publicado: (2021)

Metals in Imaging of Alzheimer’s Disease
por: Krasnovskaya, Olga, et al.
Publicado: (2020)

Aβ-Targeting Bifunctional Chelators (BFCs) for Potential Therapeutic and PET Imaging Applications
por: Krasnovskaya, Olga, et al.
Publicado: (2022)

Tacrine-Based Hybrids: Past, Present, and Future
por: Bubley, Anna, et al.
Publicado: (2023)

Copper Coordination Compounds as Biologically Active Agents
por: Krasnovskaya, Olga, et al.
Publicado: (2020)

Recent Advances in Light-Controlled Activation of Pt(IV) Prodrugs
por: Spector, Daniil, et al.
Publicado: (2022)

(64)Cu-based Radiopharmaceuticals in Molecular Imaging
por: Zhou, Yeye, et al.
Publicado: (2019)

Copper Coordination Chemistry of Sulfur Pendant Cyclen Derivatives: An Attempt to Hinder the Reductive-Induced Demetalation in (64/67)Cu Radiopharmaceuticals
por: Tosato, Marianna, et al.
Publicado: (2021)

Harnessing (64)Cu/(67)Cu for a theranostic approach to pretargeted radioimmunotherapy
por: Keinänen, Outi, et al.
Publicado: (2020)

Theragnostic (64)Cu/(67)Cu Radioisotopes Production With RFT-30 Cyclotron
por: Lee, Jun Young, et al.
Publicado: (2022)

Estimation of biological effect of Cu-64 radiopharmaceuticals with Geant4-DNA simulation
por: Kusumoto, Tamon, et al.
Publicado: (2022)

Increasing Reaction Rates of Water-Soluble Porphyrins for (64)Cu Radiopharmaceutical Labeling
por: Pęgier, Mateusz, et al.
Publicado: (2023)

The Efficient Synthesis and Biological Evaluation of Novel Bi-Functionalized Sarcophagine for (64)Cu Radiopharmaceuticals
por: Liu, Shuanglong, et al.
Publicado: (2012)

An abbreviated therapy-dosimetric equation for the companion diagnostic/therapeutic [(64/67)Cu]Cu-SARTATE
por: Laffon, Eric, et al.
Publicado: (2021)

Theragnostic Radionuclide Pairs for Prostate Cancer Management: (64)Cu/(67)Cu, Can Be a Budding Hot Duo
por: Chhabra, Anupriya, et al.
Publicado: (2022)

Radionuclide Cisternography with [(64)Cu]Cu-DOTA
por: Greiser, Julia, et al.
Publicado: (2023)

Evaluation of (64)Cu-Based Radiopharmaceuticals that Target Aβ Peptide Aggregates as Diagnostic Tools for Alzheimer’s Disease
por: Bandara, Nilantha, et al.
Publicado: (2017)

Recent Advances in Nanopore Technology for Copper Detection and Their Potential Applications
por: Vaneev, Alexander N., et al.
Publicado: (2023)

Detection and therapy of neuroblastoma minimal residual disease using [(64/67)Cu]Cu-SARTATE in a preclinical model of hepatic metastases
por: Dearling, Jason L. J., et al.
Publicado: (2021)

(64)Cu-ATSM/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study
por: Pérès, Elodie A., et al.
Publicado: (2019)

Comparison of the Effects of DOTA and NOTA Chelators on (64)Cu-Cudotadipep and (64)Cu-Cunotadipep for Prostate Cancer
por: Lee, Inki, et al.
Publicado: (2023)

ET-7 EVALUATION OF HYPOXIA-TARGETING RADIOPHARMACEUTICAL(64)CU-ATSM FOR PET MONITORING WITH LOCAL THERAPY IN HIGH-GRADE GLIOMA MODEL
por: Yoshii, Yukie, et al.
Publicado: (2022)

Is (70)Zn(d,x)(67)Cu the Best Way to Produce (67)Cu for Medical Applications?
por: Nigron, Etienne, et al.
Publicado: (2021)

[(64)Cu]Cu-DOTATATE PET metrics in the investigation of atherosclerotic inflammation in humans
por: Jensen, Jacob K., et al.
Publicado: (2022)

A feasibility study of the therapeutic application of a mixture of (67/64)Cu radioisotopes produced by cyclotrons with proton irradiation
por: De Nardo, Laura, et al.
Publicado: (2022)

An Overview of In Vitro Assays of (64)Cu-, (68)Ga-, (125)I-, and (99m)Tc-Labelled Radiopharmaceuticals Using Radiometric Counters in the Era of Radiotheranostics
por: Benfante, Viviana, et al.
Publicado: (2023)

Cyclotron-Based Production of (67)Cu for Radionuclide Theranostics via the (70)Zn(p,α)(67)Cu Reaction
por: Brühlmann, Santiago Andrés, et al.
Publicado: (2023)

Magnetic moment of $^{67}$Ni and $^{67}$Ni $\rightarrow ^{67}$Cu $\beta$-decay
por: Ríkovská, J, et al.
Publicado: (1996)

Synthesis and evaluation of (64)Cu-radiolabeled NOTA-cetuximab ((64)Cu-NOTA-C225) for immuno-PET imaging of EGFR expression
por: Xu, Xiaoxia, et al.
Publicado: (2019)

(64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry
por: Hansen, Anders E, et al.
Publicado: (2012)

The somatostatin receptor 2 antagonist (64)Cu-NODAGA-JR11 outperforms (64)Cu-DOTA-TATE in a mouse xenograft model
por: Rylova, Svetlana N., et al.
Publicado: (2018)

Recent Advances in Barrier Layer of Cu Interconnects
por: Li, Zhi, et al.
Publicado: (2020)

Analytical Models for Measuring the Mechanical Properties of Yeast
por: Savin, Nikita, et al.
Publicado: (2023)

(67)Cu Production Capabilities: A Mini Review
por: Mou, Liliana, et al.
Publicado: (2022)

Effect of intratumoral administration on biodistribution of (64)Cu-labeled nanoshells
por: Xie, Huan, et al.
Publicado: (2012)

Integrated (64)Cu therapy for the peritoneal dissemination of gastrointestinal cancer
por: Kurihara, Hiroaki
Publicado: (2018)

Pilot Study of (64)Cu(I) for PET Imaging of Melanoma
por: Jiang, Lei, et al.
Publicado: (2017)

(64)Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors
por: Mirzaei, Siroos, et al.
Publicado: (2019)

Effect of Liraglutide on Vascular Inflammation Evaluated by [(64)Cu]DOTATATE
por: Zobel, Emilie H., et al.
Publicado: (2021)

Tissue acidosis does not mediate the hypoxia selectivity of [(64)Cu][Cu(ATSM)] in the isolated perfused rat heart
por: Baark, Friedrich, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uk0js0uuu0p2a7975h76ncub9k